Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > "Griproom" article - 10 signs your company is to be acquired

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Oct 19, 2023 1:16pm

126 Views

Post# 35691214

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:"Griproom" article - 10 signs your company is to be acquired

OK Foxy ... out of the mouth of babies comes your own words ..

" I've sold" ...and ... "Just because you are wrong like 100% of the time you don't need to conjure up nonsense."

But yet being 100% wrong you do. So bye.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program